Cansortium Analyst Sees 'Dramatic Expansion' Potential In Canadian Cannabis Market

Cansortium Inc CNTMF is a vertically integrated multistate operator that is well-positioned for "dramatic expansion," according to Canaccord Genuity. 

The Analyst

Bobby Burleson initiated coverage of Cansortium's Canada-listed stock with a Speculative Buy rating and $2.50 price target.

The Thesis

Cansortium's focus is on the medical cannabis space in Florida, where it oversees 11 dispensaries and is considered a "large player" in the regulated cannabis market, Burleson said in the Friday initiation note. (See his track record here.) 

The company's market share in Florida is likely to increase from 6% in 2019 to 11% in 2020, with plans to open 19 more stores by the end of the year, the analyst said. 

Part of the growth story comes from Cansortium's expansion potential in new markets, Burleson said.

The company should see initial contributions from the province of Ontario and from Michigan in the fourth quarter, he said. Coupled with the opportunity in Florida, Cansortium could address a total addressable market of $3 billion in 2020, the analyst said. 

The company also faces "significant" longer-term opportunities in Pennsylvania from its application for a clinical registrant license, along with "rapidly evolving" regulations in Texas, Burleson said. 

Finally, Cansortium's ongoing operations in Puerto Rico and a subsidiary in Latin America create the potential to be a first-mover in the region, according to Canaccord. 

Price Action

Cansortium's over-the-counter shares were 4.47% higher at $1.62 at the close Friday. 

Related Links:

How Are New Innovations Driving The Cannabis Market Growth?

The Queen Goes Green: UK's Centre For Medicinal Cannabis Releases New Report On CBD

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorCannabisPenny StocksPrice TargetInitiationMarketsAnalyst RatingsBobby BurlesonCanaccord Genuitymarijuanamedical cannabismultistate operatorspotweed
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!
CCC-Oct-24-Banner-1

Click on the image for more info.

Cannabis rescheduling seems to be right around the corner

Want to understand what this means for the future of the industry?

Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. 

Get your tickets now before prices surge by following this link.